From the emergency ward to pitching an IPO

On June 17, 2019

Sean Parsons was a medical emergency doctor during the 2009 swine flu pandemic in Queensland when he decided to develop a home-test kit for the flu.

Flu-diagnostics startup Ellume raises $5 million as it gears up for IPO

On June 17, 2019

Brisbane Medtech startup Ellume has secured $5 million in funding for commercialising and developing its diagnostics products as it ramps up to listing on the ASX.

Ellume Appoints CFO And CBO

On April 23, 2019

Brisbane, Australia – 23rd April 2019 Ellume Limited (Ellume) is pleased to announce the appointment of David Green as Chief Financial Officer and Company Secretary, and Mark Boyle Chief Business Officer of the Company. These appointments strengthen the management of the company in preparation for US commercialisation and potential ASX IPO later this year. David […]

Ellume, the digital diagnostics company helping people beat the flu

On April 12, 2019

Dr Sean Parsons is the founder of Ellume, an emerging digital diagnostics company situated in Brisbane that provides smart, self-use diagnostics for the detection and management of pandemic influenza.

Meet the Aussie entrepreneur letting you diagnose the flu through your smartphone

On April 11, 2019

Imagine being able to accurately diagnose common illnesses such as the flu, submit that diagnosis to a medical professional, and receive advice and a prescription for treatment, all without ever having to leave your bed.

Ellume announces another global partnership – this time with QIAGEN on the detection of tuberculosis

On January 8, 2019

Highlights Australia’s Ellume Limited has partnered with QIAGEN N.V. to bring the next generation of latent TB testing to low-resource, high-burden countries The deal includes the licensing of Ellume technologies and a USD $15M minority investment by QIAGEN in Ellume Limited This announcement builds on the recent announcement of a global partnership with GlaxoSmithKline announced […]

Medical diagnostics firm Ellume gets German backing for TB testing

On January 7, 2019

7 January 2019, Peter Williams This article originally appeared in The Australian, print and online, on 7th January 2019. View the original here on The Australian Website. Brisbane medical diagnostics company Ellume has received a $US15 million ($21m) investment from German biotech Qiagen as part of a broader strategic partnership between the two companies to detect tuberculosis. Clinical trials for a […]

Ellume spreads global wings with GSK deal

On December 11, 2018

11 December 2018, Sarah-Jane Tasker This article originally appeared in The Australian, print and online, on 11th December 2018. View the original here on The Australian Website. Brisbane medical diagnostics company Ellume has signed a significant deal with pharmaceutical giant GSK for digital consumer products, ahead of a potential market listing. Ellume founder and managing directory Sean Parsons said the […]